Selected DDDC Publications
Books:
Bellack, A. S., Mueser, K. T., Gingerich, S., & Agresta, J. (1997) Social Skills Training for Schizophrenia: A Step-by-Step Guide NY:Guilford Publications
Drake, R. E., & Mueser, K. T. (Eds.) (1996) Dual Diagnosis of Major Mental Illness and Substance Abuse: New Directions for Mental Health Services. Volume 2: Recent Research and Clinical Implications NY:Jossey-Bass
Drake, R.E., Mercer-McFadden, C., McHugo, G.J.. Mueser, K.T., Rosenberg, S.D., Clark, R.E., & Brunette, M.F. (Eds.) (1998) Readings in Dual Diagnosis , International Association of Psychosocial Rehabilitation Services
Drake, R.E., Merrens, M.R., & Lynde, David W., (2005) Evidence-based mental health practice: A textbook, NY:Norton
Mercer-McFadden, C., Robert E. Drake, R.E., Clark, R. E., Verven, N., Noordsy, D. L. & Fox, T. S. (1998) Substance Abuse Treatment for People with Severe Mental Disorders: A Program Manager's Guide , Lebanon: New Hampshire-Dartmouth Psychiatric Research Center
Mueser, K.T. & Gingerich, S. (1994) Coping with Schizophrenia: A Guide for Families Oakland: New Harbinger Publications
Mueser, K.T. & Tarrier, N. (Eds.) (1998) Handbook of Social Functioning in Schizophrenia NY: Allyn and Bacon
Mueser, K.T. &Glynn, S. (1999) . Behavioral Family Therapy for Psychiatric Disorders, Second Edition Oakland: New Harbinger Publications.
Mueser, K.T., Drake, R.E., Clark, R.E., McHugo, G.J., Mercer-McFadden, C., & Ackerson, T.H., (1995) Toolkit: Evaluating Substance Abuse in Persons with Severe Mental Illness The Evaluation Center @ HSRI
Mueser, K.T., Noordsy, D.L., Drake, R.E. & Fox, L. (2003) Integrated Treatment for Dual Disorders: A Guide to Effective Practice NY: Guilford Publications
Recent Journal Articles (2001 to present):
Alverson, H., Alverson, M., & Drake, R.E. Social patterns of substance use among people with dual diagnoses. Mental Health Services Research, 3(1), 3-14, 2001.
Angres, D.H., McGovern, M.P., Rawal, P., & Shaw, M. Psychiatric comorbidity and physicians with substance use disorders: Clinical characteristics, treatment experiences, and post-treatment functioning. Addictive Disorders & Their Treatment, 1(3), 89-98, 2002.
Angres, D.H., McGovern, M.P., Shaw, M., & Rawal, P. Psychiatric comorbidity and physicians with substance use disorders: A comparison between the 1980s and 1990s. Journal of Addictive Diseases, 22(3), 79-87, 2003.
Brunette, M., Noordsy, D.L., Xie, H., & Drake, R.E., Benzodiazepine Use and Abuse Among Patients With Severe Mental Illness and Co-occurring Substance Use Disorders. Psychiatric Services, 54(10), 1395-1401, 2003.
Brunette, M.B., Noordsy, D.L., Buckley, P., & Green, A.I. Pharmacologic treatments for co-occurring substance use disorders in patients with schizophrenia: A research review. Journal of Dual Diagnosis, 1, 41-55, 2005.
Brunette, M.F., Drake, R.E., Woods, M., & Hartnett, T. A comparison of long-term and short-term residential treatment programs for dual diagnosis patients. Psychiatric Services, 52(4), 526-528, 2001.
Brunette, M.F., Mueser, K.T., & Drake, R.E. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug and Alcohol Review, 23, 471-481, 2004.
Caton, C., Drake, R.E., Hasin, D.S., Dominguez, B., Shrout, P., Samet, S., & Schanzer, W.B. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Archives of General Psychiatry, 62, 137-145, 2005.
Clark, R.E. Family support and substance use outcomes for persons with mental illness and substance use disorders. Schizophrenia Bulletin, 27(1), 93-101, 2001.
Clark, R.E., & Mueser, K.T. Progress in research on dual disorders. British Journal of Psychiatry, 183, 337-378, 2003.
Clark, R.E., Xie, H., & Brunette, M. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. Journal of Clinical Psychiatry, 65, 151-155, 2004.
Clark, R.E., Xie, H., Adachi-Mejia, A.M., & Sengupta, A. Substitution between formal and informal care for persons with severe mental illness and substance use disorders. Journal of Mental Health Policy and Economics, 4, 123-132, 2001.
Crocker, A.G., Mueser, K.T., Drake, R.E., Clark, R.E., McHugo, G.J., Ackerson, T.H., & Alterman, A.I. Antisocial personality, psychopathy, and violence in persons with dual disorders. Criminal Justice and Behavior, 32, 452-476, 2005.
Dickey, B., Norman, S.-L., Weiss, R.D., Drake, R.E., & Azeni, H. Medical morbidity, mental illness, and substance use disorders. Psychiatric Services, 53(7), 861-867, 2002.
Dickey, B., Normand, S.T., Drake, R.E., Weiss, R., Azeni, H., & Hanson, A. Limiting inpatient substance use treatment: What are the consequences? Medical Care Research and Review, 60(3), 332-346, 2003.
Drake, R.E. Dual Diagnosis. Psychiatry, 3, 60-63, 2004.
Drake, R.E., & Mueser, K.T. Co-occurring alcohol use disorder and schizophrenia. Alcohol Research & Health, 26 (2), 99-102, 2002.
Drake, R.E., & Mueser, K.T. Managing comorbid schizophrenia and substance abuse. Current Psychiatry Reports, 3(5), 418-422, 2001.
Drake, R.E., Brunette, M.F., Mueser, K.T., & Green, A.I. Management of patients with severe mental illness and co-occurring substance use disorder. Minerva Psichiatrica, 46, 119-132, 2005.
Drake, R.E., Essock, S.M., Shaner, A., Carey, K.B., Minkoff, K., Kola, L., Lynde, D., Osher, F.C., Clark, R.E., & Richards, L. Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services, 52(4), 469-476, 2001.
Drake, R.E., Merrens, M.R., & Lynde, D.W. (Eds.). Evidence-Based Mental Health Practice: A Textbook (First ed.). New York: W. W. Norton & Company, Inc., 2005.
Drake, R.E., Morse, G.A., Brunette, M., & Torrey, W.C. Evolving U.S. service model for patients with severe mental illness and co-occurring substance use disorder. Acta Neuropsychiatrica, 16, 36-40, 2004.
Drake, R.E., Mueser, K.T., Brunette, M., & McHugo, G.J. A review of treatments for people with severe mental illness and co-occurring substance use disorder. Psychiatric Rehabilitation Journal, 27, 360-374, 2004.
Drake, R.E., Wallach, M.A., & McGovern, M.P. Future directions in preventing relapse to substance abuse among clients with severe mental illness. Psychiatric Services, 56, 1297-1302, 2005.
Drake, R.E., Wallach, M.A., Alverson, H.S., & Mueser, K.T. Psychosocial aspects of substance abuse by clients with severe mental illness. Journal of Nervous and Mental Disease, 190, 100-106, 2002.
Drake, R.E., Xie, H., McHugo, G.J., & Shumway, M. Three-year outcomes of patients with severe bipolar disorder and co-occurring substance use disorders. Biological Psychiatry, 56, 749-756, 2004.
Essock, S., Mueser, K.T., Drake, R.E., Covell, N., McHugo, G.J., Frisman, L., Kontos, N., Jackson, C., Townsend, F., & Swain, K. Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders. Psychiatric Services, 57, 185-196, 2006.
Graham, H.L., Copello, A., Birchwood, M., & Mueser, K.T. (Eds.). Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester, UK: John Wiley & Sons, Ltd., 2002.
Graham, H.L., Maslin, J., Copello, A., Birchwood, M., Mueser, K., McGovern, D., & Georgiou, G. Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK. Social Psychiatry Psychiatric Epidemiology, 36, 448-455, 2001.
Green, A.I., Burgess, E.S., Dawson, R., Zimmet, S.V., & Strous, R.D. Alcohol and cannabis use in schizophrenia: Effects of clozapine vs. risperidone. Schizophrenia Research, 60, 81-85, 2003.
Green, A.I., Canuso, C.M., Brenner, M.J., & Wojcik, J.D. Detection and management of comorbidity in patients with schizophrenia. Psychiatric Clinics of North America, 26, 115-139, 2003.
Green, A.I., Chau, D.T., Keung, W.M., Dawson, R., Mesholam, R.I., & Schildkraut, J.J. Clozapine reduces alcohol drinking in Syrian golden hamsters. Psychiatry Research, 128, 9-20, 2004.
Green, A.I., Tohen, M.F., Hamer, R.M., Strakowski, S.M., Lieberman, J.A., Glick, I., Clark, W.S., & HGDH Research Group. First episode schizophrenia-related psychosis and substance use disorders: Acute response to olanzapine and haloperidol. Schizophrenia Research, 66, 125-135, 2004.
Jackson, C.T., Fein, D., Essock, S.M., & Mueser, K.T. The effects of cognitive impairment and substance abuse on psychiatric hospitalizations. Community Mental Health Journal, 37,(4), 303-312, 2001.
Kavanagh, D., Mueser, K.T., & Baker, A. Management of comorbidity. In M. Teeson & H. Proudfoot (Eds.), Comorbid Mental Disorders and Substance Use Disorders: Epidemiology, Prevention and Treatment (pp. 78-120). Sydney, Australia: National Drug and Alcohol Research Centre, University of New South Wales, 2004.
Maslin, J., Graham, H.L., Cawley, M., A, C., Birchwood, M., Georgiou, G., McGovern, D., Mueser, K., & Orford, J. Combined severe mental health and substance use problems: What are the training and support needs of staff working with this client group? Journal of Mental Health, 10(2), 131-140, 2001.
McGovern, M.P., & Carroll, K.M. Evidence-based practices for substance use disorders. Psychiatric Clinics of North America, 26(4), 991-1010, 2003.
McGovern, M.P., Fox, T.S., Xie, H., & Drake, R.E. A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in an a iction treatment system. Journal of Substance Abuse Treatment, 26, 305-312, 2004.
McGovern, M.P., Wrisley, B.R., & Drake, R.E. Relapse of substance use disorder and its prevention among persons with co-occurring disorders. Psychiatric Services, 56, 1270-1273, 2005.
McHugo, G.J., Bebout, R.R., Harris, M., Cleghorn, S., Herring, G., Xie, H., Becker, D.R., & Drake, R.E. A randomized controlled trial of integrated versus parallel housing services for homeless adults with severe mental illness. Schizophrenia Bulletin, 30, 969-982, 2005.
McHugo, G.J., Kammerer, N., Jackson, E.W., Markoff, L.S., Gatz, M., Larson, M.J., Mazelis, R., & Hennigan, K. Women, co-occurring disorders, and violence study: Evaluation design and study population. Journal of Substance Abuse Treatment, 28, 91-107, 2005.
Mueser, K.T. Clinical interventions for severe mental illness and co-occurring substance use disorder. Acta Neuropsychiatrica, 16, 26-35, 2004.
Mueser, K.T., & Fox, L. A family intervention program for dual disorders. Community Mental Health Journal, 38, 253-270, 2002.
Mueser, K.T., & Lewis, S. Treatment of substance misuse in schizophrenia. In P. Buckley & J. Waddington (Eds.), Schizophrenia and Mood Disorders: The New Drug Therapies in Clinical Practice (pp. 286-296). Oxford: Butterworth & Heinemann, 2000.
Mueser, K.T., Bond, G.R., Foster, F.P., & Lynde, D. Psychosocial and rehabilitation treatments for patients with severe mental illness. CNS Spectrums, 9, 891, 2004.
Mueser, K.T., Drake, R.E., Sigmon, S.C., & Brunette, M. Psychosocial interventions for adults with severe mental illnesses and co-occurring substance use disorders: A review of specific interventions. Journal of Dual Diagnosis, 1, 57-82, 2005.
Mueser, K.T., Essock, S.M., Drake, R.E., Wolfe, R., & Frisman, L. Rural and urban differences in patients with a dual diagnosis. Schizophrenia Research, 48, 93-107, 2001.
Mueser, K.T., Noordsy, D.L., Drake, R.E., & Fox, M. Integrated Treatment for Dual Disorders: A Guide to Effective Practice. New York: The Guilford Press 2003.
Mueser, K.T., Noordsy, D.L., Fox, L., & Wolfe, R. Disulfiram treatment for alcoholism in severe mental illness. The American Journal of Addictions, 12, 242-252, 2003.
Mueser, K.T., Torrey, W.C., Lynde, D., Singer, P., & Drake, R.E. Implementing evidence-based practices for people with severe mental illness. Behavior Modification, 27(3), 387-411, 2003.
Mueser, K.T., Yarnold, P.R., Rosenberg, S.D., Swett, C., Miles, K.M., & Hill, D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: Prevalence, correlates, and subgroups. Schizophrenia Bulletin, 26(1), 179-192, 2000.
Noordsy, D.L., & Green, A.I. Pharmacotherapy for schizophrenia and co-occurring substance use disorders. Current Psychiatry Reports, 5, 340-346, 2003.
O'Brien, C.P., Charney, D.S., Lewis, L., & Depression Bipolar Support Association. Commentary: Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: A call to action. Biological Psychiatry, 56, 703-713, 2004.
Sacks, J., Drake, R.E., Williams, V.F., Banks, S.M., & Herrell, J.M. Utility of the Time-Line Follow-Back to assess substance use among homeless adults. The Journal of Nervous and Mental Disease, 191(3), 145-153, 2003.
Salyers, M.P., & Mueser, K.T. Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophrenia Research, 48, 109-123, 2001.
Shaw, M., McGovern, M.P., Angres, D.H., & Rawal, P. Physicians and nurses with substance use disorders. Journal of Advanced Nursing, 47, 561-571, 2004.
Torrey, W.C., Drake, R.E., Cohen, M., Fox, L.B., Lynde, D., Gorman, P., & Wyzik, P. The challenge of implementing and sustaining integrated dual disorders treatment programs. Community Mental Health Journal, 38 (6), 507-521, 2002.
Xie, H., McHugo, G.J., Fox, L., & Drake, R.E. Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders. Psychiatric Services, 56, 1282-1287, 2005.
Xie, H., McHugo, G.J., Helmstetter, B.S., & Drake, R.E. Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders. Schizophrenia Research, 75, 337-348, 2005.
Xie, H., McHugo, G.J., Sengupta, A., & Drake, R.E. Using discrete-time survival analysis to examine patterns of remission from substance use disorder among persons with severe mental illness. Mental Health Services Research, 5 (1), 55-64, 2003.
Xie, H., McHugo, G.J., Sengupta, A., Clark, R.E., & Drake, R.E. A method for analyzing longitudinal outcomes with many zeros. Mental Health Services Research, 6, 239-246, 2004.
Xie, H., McHugo, G.J., Sengupta, A., Hedeker, D., & Drake, R.E. An application of the thresholds of change model to the analysis of mental health data. Mental Health Services Research, 3,(2), 107-114, 2001.
Ziedonis, D.M., Smelson, D., Rosenthal, R.N., Batki, S.L., Green, A.I., Henry, R.J., Montoya, I., Parks, J., & Weiss, R.D. Improving the care of individuals with schizophrenia and substance use disorders: Consensus recommendations. Journal of Psychiatric Practice, 11, 315-339, 2005.